LifeMD EPS - Earnings per Share 2011-2024 | LFMD

LifeMD eps - earnings per share from 2011 to 2024. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
LifeMD Annual EPS
2023 $-0.70
2022 $-1.57
2021 $-2.29
2020 $-4.44
2019 $-0.32
2018 $-0.15
2017 $-0.15
2016 $-0.15
2015 $0.00
2014 $-0.10
2013 $-0.05
2012 $-0.10
2011 $-0.10
2010 $-0.10
LifeMD Quarterly EPS
2024-03-31 $-0.19
2023-12-31 $-0.12
2023-09-30 $-0.20
2023-06-30 $-0.23
2023-03-31 $-0.15
2022-12-31 $-0.40
2022-09-30 $-0.26
2022-06-30 $-0.45
2022-03-31 $-0.46
2021-12-31 $-0.64
2021-09-30 $-0.54
2021-06-30 $-0.64
2021-03-31 $-0.47
2020-12-31 $-2.29
2020-09-30 $-1.65
2020-06-30 $-0.27
2020-03-31 $-0.23
2019-12-31 $-0.03
2019-09-30 $-0.09
2019-06-30 $-0.10
2019-03-31 $-0.10
2018-12-31 $0.00
2018-09-30 $-0.10
2018-06-30 $-0.10
2018-03-31 $0.05
2017-12-31 $-0.05
2017-09-30 $-0.05
2017-06-30 $0.10
2017-03-31 $-0.15
2016-12-31 $-0.05
2016-09-30 $-0.05
2016-06-30 $-0.05
2016-03-31 $0.00
2015-12-31 $0.00
2015-09-30 $0.00
2015-06-30 $0.00
2015-03-31 $0.00
2014-12-31 $0.00
2014-09-30 $0.00
2014-06-30 $0.00
2014-03-31 $0.00
2013-12-31 $0.00
2013-09-30 $0.00
2013-06-30 $0.00
2013-03-31 $0.00
2012-12-31 $0.00
2012-09-30 $-0.05
2012-06-30 $-0.05
2012-03-31 $0.00
2011-12-31 $0.00
2010-12-31 $0.00
Sector Industry Market Cap Revenue
Medical Medical Services $0.329B $0.153B
LifeMD Inc. is a telehealth company. It offers a full portfolio of direct-to-patient products and services. The company combines virtual medical treatment with prescription medications and unique over-the-counter products. Its network of licensed physicians offers telemedicine services and direct-to-consumer pharmacy to consumers. LifeMD Inc., formerly known as Conversion Labs, is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $124.299B 15.60
Cencora (COR) United States $46.379B 18.08
ICON (ICLR) Ireland $25.848B 24.40
DiDi Global (DIDIY) China $20.706B 0.00
Avantor (AVTR) United States $14.726B 21.68
CochLear (CHEOY) Australia $13.973B 0.00
Natera (NTRA) United States $13.533B 0.00
Revvity (RVTY) United States $13.407B 23.52
Medpace Holdings (MEDP) United States $12.205B 40.15
Viatris (VTRS) United States $12.109B 3.62
EUROFINS SCIENT (ERFSF) Luxembourg $10.989B 0.00
Charles River Laboratories (CRL) United States $10.790B 20.66
Solventum (SOLV) United States $9.423B 0.00
Sonic Healthcare (SKHHY) Australia $7.951B 0.00
HealthEquity (HQY) United States $7.177B 46.08
Doximity (DOCS) United States $5.537B 38.78
Bausch + Lomb (BLCO) Canada $5.309B 21.25
Organon (OGN) United States $5.246B 4.98
PACS (PACS) United States $4.392B 0.00
Life Times (LTH) United States $3.563B 37.33
Sotera Health (SHC) United States $3.281B 16.10
GoodRx Holdings (GDRX) United States $3.193B 121.57
Surgery Partners (SGRY) United States $3.177B 29.07
Agilon Health (AGL) United States $2.838B 0.00
Progyny (PGNY) United States $2.569B 44.23
NovoCure (NVCR) Jersey $2.296B 0.00
AMN Healthcare Services Inc (AMN) United States $2.102B 8.33
Premier (PINC) United States $1.927B 8.24
BrightSpring Health Services (BTSG) United States $1.794B 0.00
Teladoc Health (TDOC) United States $1.696B 0.00
Alignment Healthcare (ALHC) United States $1.591B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.566B 0.00
Establishment Labs Holdings (ESTA) $1.224B 0.00
GeneDx Holdings (WGS) United States $0.752B 0.00
CareDx (CDNA) United States $0.739B 0.00
Embecta (EMBC) United States $0.738B 5.02
InnovAge Holding (INNV) United States $0.691B 0.00
Pediatrix Medical (MD) United States $0.609B 6.46
Auna S.A (AUNA) Luxembourg $0.600B 0.00
QDM (QDMI) Hong Kong, SAR China $0.583B 15.27
COMPASS Pathways (CMPS) United Kingdom $0.455B 0.00
Enhabit (EHAB) United States $0.441B 44.00
ModivCare (MODV) United States $0.375B 7.02
Sonida Senior Living (SNDA) United States $0.369B 0.00
DocGo (DCGO) United States $0.294B 16.06
Sharecare (SHCR) United States $0.292B 0.00
MultiPlan (MPLN) United States $0.281B 0.00
Sera Prognostics (SERA) United States $0.261B 0.00
Beauty Health (SKIN) United States $0.244B 0.00
Ascend Wellness Holdings (AAWH) United States $0.196B 0.00
Biodesix (BDSX) United States $0.184B 0.00
So-Young (SY) China $0.114B 55.25
Pono Capital Two (PTWO) United States $0.072B 0.00
Co-Diagnostics (CODX) United States $0.050B 0.00
NeueHealth (NEUE) United States $0.044B 5.99
IceCure Medical (ICCM) Israel $0.037B 0.00
Oncology Institute (TOI) United States $0.034B 0.00
Nutex Health (NUTX) United States $0.027B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.027B 0.00
BIMI Holdings (BIMI) United States $0.024B 0.00
Singular Genomics Systems (OMIC) United States $0.024B 0.00
OncoCyte (OCX) United States $0.023B 0.00
KindlyMD (KDLY) $0.016B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
DermTech (DMTK) United States $0.011B 0.00
XWELL (XWEL) United States $0.011B 0.00
TRxADE HEALTH (MEDS) United States $0.009B 0.00
BioNexus Gene Lab (BGLC) $0.008B 0.00
ISpecimen (ISPC) United States $0.007B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
NewGenIvf Group (NIVF) Singapore $0.004B 0.00
OpGen (OPGN) United States $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Assure Holdings (IONM) United States $0.002B 0.00